OPB Flashcards

(38 cards)

1
Q

Side effects of Tamoxifen

A
Menstrual disturbance: vaginal bleeding, amenorrhoea
hot flushes - 3% of patients stop taking tamoxifen due to climateric side-effects
Venous thromboembolism
Endometrial changes- hyperplasia, polyps, cancer, uterine sarcoma
Alopecia
Anaemia
Cataracts
Cerebral ischaemia
Embolism
Fatigue
Fluid retention
Headache
Nausea
Retinopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mechanism if action of tamoxifen

A

Oestrogen receptor antagonist- prevents oestrogen binding so blocking the proliferative action and inhibiting tumour growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Indications for tamoxifen

A

ER+ breast cancer post-surgery
Breast cancer patients for 5 years after tumour removal
Primary prevention of breast cancer (i women >30 at moderate/ high risk)
Gynaecomastia in males
Treatment of anovulatory infertility

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Contraindications for tamoxifen

A

Family/ personal history of idiopathic VTE
Pregnancy- must be on effective contraception prior to, during and for 2 months after treatment
Concurrent anastrozole therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Examples of aromatase inhibitors

A

Exemestane, letrozole, anastrozole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Mechanism of action of exemestane

A

Inhibits the aromatase enzyme to stop the conversion of androgens to oestrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Mechanism of action of letrozole

A

Inhibits the aromatase enzyme to stop the conversion of androgens to oestrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mechanism of action of anastrozole

A

Inhibits the aromatase enzyme to stop the conversion of androgens to oestrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Mechanism of action of goserelin

A

GnRH receptor agonist- stimulates production of LH and FSH which eventually negatively feedbacks and down-regulates oestrogen and testosterone production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Mechanism of action of herceptin

A

Monoclonal antibodies which down-regulates HER2 receptors and decreases cell proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Contraindications to aromatase inhibitors

A

Pre-menopausal women (high levels of circulating oestrogen)

Pregnancy/breast feeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Side effects of aromatase inhibitors

A
Alopecia
Hot flushes
Vaginal dryness
Oedema
Bone pain
Headache
GI upset
Carpal tunnel syndrome
Insomnia
Leukopenia
Thrombocytopenia
Skin reactions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Side effects of aromatase inhibitors

A
DECREASED BONE MINERAL DENSITY
Alopecia
Hot flushes
Vaginal dryness
Oedema
Bone pain
Headache
GI upset
Carpal tunnel syndrome
Insomnia
Leukopenia
Thrombocytopenia
Skin reactions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Method of administration of goserelin

A

SC injection in the anterior abdominal wall every 28 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Indications for goserelin

A

Locally advanced prostate cancer (as an alternative to surgery)
Adjuvant/Neoadjuvant treatment to radiotherapy/radical prostatectomy in patients with high-risk localised or locally advanced prostate cancer
Metastatic prostate cancer
Advanced breast cancer
ER+ early breast cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Indications for goserelin

A

Locally advanced prostate cancer (as an alternative to surgery)
Adjuvant/Neoadjuvant treatment to radiotherapy/radical prostatectomy in patients with high-risk localised or locally advanced prostate cancer
Metastatic prostate cancer
Advanced breast cancer
ER+ early breast cancer

17
Q

Cautions for taking goserelin

A
Depression
Diabetes
Hypertension
Metabolic bone disease
PCOS
18
Q

Cautions for taking goserelin

A
Depression
Diabetes
Hypertension
Metabolic bone disease
PCOS
Risk of spinal cord compression
Risk of ureteric obstruction in men
19
Q

Side effects of goserelin

A
Alopecia
Pain
Breast abnormalities
Altered mood/ depression
Impairment glucose tolerance
Gynaecomastia
Headache
Heart failure
Hot flushes
Hyperhidrosis
MI
Neoplasm complication
Paraesthesia
Sexual dysfunction
Skin reaction
Spinal cord compression
Vulvovaginal disorder
Increased weight
20
Q

Indications for herceptin

A

Early HER2+ breast cancer
Metastatic HER2+ breast cancer patients who have not received chemotherapy and where Anthracycline treatment is inappropriate (given in combination with paclitaxel or docetexal)
Monotherapy for metastatic breast cancer patients who have previously received at least 2 chemotherapy agents
Metastatic HER2+, ER/PR+ breast cancer in post-menopausal patients not previously treated with trastuzumab (given in combination with an
aromatase inhibitor)
Metastatic HER2+ gastric cancer (given in combination with cisplatin and Capecitabine or 5-fluorouracil)

21
Q

Side effects of herceptin

A
CONGESTIVE HEART FAILURE
Headache
GI upset and weight loss
Insomnia
Cough
Rash
Cardiac symptoms: Arrthymias, palpitation
Infection (neutropenic sepsis) 
Pancytopenia
Fatigue
Malaise
Pain
Tremor 
Dizziness
Paraesthesia
Altered sense of taste
Hot flushes
Respiratory symptoms
Swollen face
Alopecia
Nail disorders
Hand-foot syndrome
Peripheral oedema
22
Q

Mechanism of action of imatinab

A

Tyrosine kinase inhibitor- inhibits proliferation and induces apoptosis

23
Q

Indications for imatinab

A

Philadelphia+ Chronic myeloid leukaemia (in chronic phase after failure with interferon alpha or in accelerated phase or blast crisis)
Philadelphia+ acute lymphoblastic leukaemia (30% of ALL)
C-Kit+ gastrointestinal stromal tumour (GIST)

24
Q

Side effects of imatinab

A
HEPATOTXICITY AND CARDIOTOXICITY
Pancytopenia
Fluid retention
GI upset
Photosensitivity
Alopecia
Myalgia, arthralgia
Blurred vision
Taste alteration
Skin changes
25
Monitoring in imatinab treatment
FBC and LFTs- hepatotoxicity and cardiotoxicity | Monitor for GI haemorrhage, fluid retention and growth retardation (in children).
26
Mechanism of action of capecitabine
Anti-metabolite. Converted into fluoruracil in cells and inhibits DNA synthesis and slows tumor growth
27
Indications for capecitabine
Monotherapy in first line treatment of advanced colorectal cancer Adjuvant therapy of patients with stage III colon cancer Advanced gastric cancer In combination with Docetexal in locally advanced or metastatic breast cancer Monotherapy in advanced breast cancer after failure of Taxane- and Anthracycline chemotherapy
28
Side effects of capecitabine
``` GI upset and appetite suppression Eye irritation Fever Alopecia Stomatitis Myelosuppression Headache Fatigue Shortness of breath Hand-foot syndrome Weakness Dermatitis Pain Peripheral oedema ```
29
Monitoring for capecitabine
Serum calcium concentration Monitoring for eye disorders and severe skin reactions including Stevens-Johnson syndrome and toxic epidermal necrosis – discontinue permanently if these occur).
30
Mechanism of action of rituximab
Anti-lymphocytic monoclonal antibody
31
Indications of rituximab
Non-Hodgkin’s lymphoma Chronic lymphocytic leukaemia Autoimmune conditions e.g. RA, pemphigus vulgaris, systemic sclerosis, SLE
32
Contraindications of rituximab
Severe infection Severe heart failure Severe uncontrolled heart disease
33
Main side effects of rituximab
Reactivation of Hepatitis B and TB infection, induced serum sickness (triad of fever, rash and arthralgia) and cytokine-releasing syndrome. All patients should be screened for Hepatitis B and TB before treatment.
34
Medications that can be given using anticipatory prescribing
Opioid Anxiolytic sedative Anti-secretory Anti-emetic
35
What can opioids be used for in palliative care?
Pain or breathlessness
36
What can anxiolytic sedatives be used for in palliative care?
Anxiety or agitation or breathlessness
37
What can anti-secretory be used for in palliative care?
Respiratory secretions
38
Risk factors for breast cancer
Age >50 Benign breast disease, especially cystic disease Proliferative types of hyperplasia and atypical hyperplasia Exposure to ionising radiation Later first childbirth History of breast cancer Family history of breast cancer in a first-degree relative – BRCA, AT and TP53 genes involved in hereditary breast cancers Hormone therapy Nulliparity Obesity